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ABSTRACT
Introduction: Self-taken specimens from men who have
sex with men (MSM) could be important in reducing high
levels of demand on sexual health services. The
performance of self-taken specimens for the detection of
Chlamydia trachomatis (CT) and Neisseria gonorrhoeae
(GC) from both pharyngeal and rectal sites in asympto-
matic MSM was assessed.
Methods: MSM were examined according to clinic
protocol: a rectal and pharyngeal swab for GC culture and
a rectal swab for the CT strand displacement assay. An
extra set of nurse-taken and self-taken pharyngeal and
rectal specimens were also requested and were tested
using the Aptima Combo 2 assay and the result compared
with the routine clinic result, which was considered the
gold standard.
Results: A total of 272 MSM was recruited and the
sensitivity and specificity of nurse-taken and patient-taken
swabs, respectively, was as follows: rectal GC: 94.9%
and 90.1% (nurse); 92.3% and 87.9% (patient); phar-
yngeal GC: 88.2% and 91.8% (nurse); 100% and 87.8%
(patient); rectal CT: 80.0% and 99.6% (nurse); 91.4% and
98.2% (patient). No significant difference in sensitivity or
specificity was observed between the nurse-taken and
the patient-taken rectal swabs for either GC or CT. For the
detection of GC from the pharynx, comparable sensitiv-
ities were achieved between nurse-taken and patient-
taken swabs (p = 0.5); however, a significant difference
in specificity was observed (p = 0.006). This was due to
a higher number of false GC-positive self-taken pharyngeal
swabs from patients with high rates (90.9%; 10/11) of
confirmed concurrent GC infection in different anatomical
sites.
Conclusions: MSM are able to collect self-taken rectal
and pharyngeal swabs that are comparable to those taken
by clinicians.
The incidence of Chlamydia trachomatis (CT) and
Neisseria gonorrhoeae (GC) infections continues to
rise in men who have sex with men (MSM), in
England and Wales.1 Some of the key factors in
onward transmission include high rates of undiag-
nosed asymptomatic CT and GC, delays in being
able to access healthcare due to increasing demand
on genitourinary medicine (GUM) services and
increasing levels of high-risk behaviour.2 3 If recent
trends in the prevalence of sexually transmitted
infections (STI) are to be reversed, novel interven-
tion strategies, which enable the rapid detection of
pathogens and the administration of appropriate
therapy, will be necessary.
Non-invasive specimens such as urine and
vulvovaginal swabs have been shown to be an
acceptable alternative to clinician-taken urethral
and endocervical specimens and are the principal
success behind screening programmes, which are
primarily targeted at young heterosexual indivi-
duals. The self-taken specimen (which may con-
tain lower levels of target agent) is, however, only
of value when examined using a nucleic acid
amplification test (NAAT), which has superior
sensitivity when compared with traditional meth-
ods of diagnostics such as enzyme immunoassays
and bacteriological culture. However, the appro-
priateness of using NAAT in MSM populations has
additional problems, because of the unvalidated
nature of dual CT and GC NAAT in extragenital
sites such as the rectum and the pharynx.
Consequently, the potential of self-taken speci-
mens to detect CT and GC in MSM has yet to be
fully explored.
The high specificity of all CT NAAT platforms
has been established in previous studies, and
although these tests have not been formally
approved by the Food and Drug Administration
for use with non-genital specimens, they have
been validated and are now widely used for
testing both pharyngeal and rectal swabs.4 5 In
contrast, the specificity of GC NAAT are very
variable between commercial platforms: with
reports of crossreactivity with other Neisseria
spp when using both the Cobas Amplicor CT/NG
test (Roche Diagnostics, West Sussex, UK) and
CT/GC strand displacement assay (SDA; Becton
Dickinson, Oxford, UK ) tests.6 To date, the only
currently available NAAT in which the GC
component has not as yet been reported to
crossreact with other Neisseria spp are the Gen-
probe Aptima Combo 2 (AC2) and GC mono-
specific assays. However, these two assays have
not been as rigorously evaluated as some of the
other platforms and further studies to determine
their specificities are warranted.6 7
It was the aim of this study to compare the
performance of self-taken versus nurse-taken speci-
mens for the detection of both CT and GC from
both pharyngeal and rectal sites, in asymptomatic
MSM patients attending GUM clinics, using the
AC2 test.
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METHODS
Subjects and recruitment
Subjects were recruited from MSM attending a single GUM clinic
in Brighton, UK, between October 2005 and May 2007. Cases were
defined as individuals asymptomatic at either or both pharyngeal
and rectal sites with confirmed infection with either GC or CT
identified on routine clinical testing (SDA for rectal CT, culture for
GC) within the past 6 weeks who had not received antibiotics
with activity against either organism during that time period. A
small number of patients was also recruited to the study (as cases)
on their initial clinic visit because they were positive for GC at the
urethra by microscopy, but were asymptomatic at both the
pharynx and the rectum. Controls were defined as MSM attending
during the same time period who were asymptomatic and negative
on the same tests outlined above at either or both sites.
Recruitment was initially performed at first presentation in
order to minimise the risk of any untreated infection or the
impact of any empiric antibiotic usage on study uptake. After a
midway review of study recruitment (December 2006), when the
number of controls far outnumbered the number of cases,
subsequent recruitment was purposively of cases until the
required number for powering the study was achieved, with a
random inclusion of controls (a minimum of one control to every
case) to maintain laboratory blinding (see below). Patients were
eligible to be included into the study more than once either as a
control or as a case if they had been appropriately treated and a
period of 6 weeks had elapsed between their last inclusion date.
Study procedures
Subjects were re-tested by the above routine clinical methods
performed by a trained GUM nurse (analysed at the local
laboratory) and then underwent further sampling tests from
both the pharyngeal and rectal sites by a nurse (nurse-taken) and
by the subject after provision of a detailed instruction sheet (self-
taken). These specimens were sent to the Sexually Transmitted
Bacteria Reference Laboratory (STBRL) where they were tested
using the AC2 assay. The laboratory team were blinded to the
identification of study subjects as either cases or controls and if
the specimen was either nurse or self-taken. Any specimen that
generated either a positive or an equivocal result for either CT or
GC was repeated using the AC2 platform and the specimens were
then stored at 4uC. At the end of the study after unblinding and
comparison with the routine gold standard result if any
discrepancy was identified in the CT or the GC results between
the nurse-taken and the self-taken swab results and/or the routine
clinic result specimens were retested with the CT or GC mono-
specific test (Gen-Probe, San Diego, California, USA).
Statistical methods and power calculation
The specificity and sensitivity of the nurse and self-taken specimens
were calculated by comparing the results generated with the
standard routine clinic result (SDA for CT detection; culture for GC
detection). For the purposes of this study the routine clinic result
was considered the gold standard. In sensitivity and specificity
calculations equivocal results were regarded as negative. Both the
sensitivity and specificity of nurse versus patient-taken specimens
were evaluated using a McNemar’s test, in STATA 10.
It was anticipated that a minimum of 212 patients would
need to be enrolled in the study (56 true positive cases of
gonorrhoea and 56 true controls) in order to detect a sensitivity
and specificity of 95% (rejecting with 80% power a sensitivity
and specificity as low as 80% and a level of significance of 0.05)
and 40 true positive cases of chlamydia and 60 true controls
would be required to give 80% power to reject the test if
sensitivity falls below 80% (against gold standard of 95%) and
specificity falls below 90% (against gold standard of 100%).
Table 1 The concordance between AC2-generated GC results for both
nurse-taken and patient-taken swabs from rectal and pharyngeal sites
and comparison with the routine GC culture result
GC culture result
Nurse-taken
swab AC2
GC result
Patient-taken
swab AC2
GC result Number*
Rectal specimens (262 patients)
2 2 2 188
+ + + 35
2 + + 17
2 2 Equ 3
2 + 2 3
2 + Equ 2
2 2 + 10
+ + 2 1
+ Equ + 1
+ + Equ 1
+ 2 2 1
Pharyngeal specimens (262 patients)
2 2 2 211
+ + + 15
2 + + 19
2 + 2 1
2 Equ 2 1
2 2 + 11
2 2 Equ 2
+ Equ + 1
+ 2 + 1
Equ, equivocal test result; 2, negative test result; +, positive test result.
*The number of participants with this combination of test results.
GC, N gonorrhoeae.
Table 2 The concordance between AC2-generated CT results for both
nurse-taken and patient-taken swabs from rectal and pharyngeal sites
and comparison with the routine clinic SDA result
SDA result
Nurse-taken
swab AC2
CT result
Patient-taken
swab AC2
CT result Number*
Rectal specimens (258 participants)
2 2 2 218
+ + + 28
2 + + 1
2 Equ 2 1
2 Equ + 1
+ Equ + 4
2 2 + 2
+ 2 Equ 1
+ 2 2 2
Pharyngeal specimens (265 participants)
2 2 257
+ + 3
2 + 2
+ Equ 1
+ 2 2
Equ, equivocal test result; 2, negative test result; +, positive test result.
*The number of participants with this combination of test results.
CT, C trachomatis; SDA, strand displacement assay.
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Consent and ethics
Approval for the study was obtained from the Brighton and
Mid-Sussex Ethics Committee. Individuals were only recruited
into the study after giving informed consent according to Good
Clinical Practice Guidelines.
RESULTS
A total of 272 study participants (made up of 267 individual
patients) was included in the study and a full set of specimen
results were generated and returned for: 262 participants (rectal
GC), 262 participants (pharyngeal GC), 258 participants (rectal
CT) and 265 participants (pharyngeal CT). The number of
study specimens positive for each infection by the ‘‘gold
standard’’ (see above) methods were: GC rectum 39 cases, GC
pharynx 17 cases and CT rectum 35 cases. Therefore, according
to the initial power calculations, although the number of GC
culture-positive cases (total 56) recruited was met, this study
fell short of the anticipated number of CT cases, despite
recruiting more patients than planned.
GC rectal and pharyngeal results
The combination of results generated from examining the three
different specimens (a GC culture and a self and nurse-taken
swab tested by AC2), from both rectal and pharyngeal sites, are
displayed in table 1. Completely concordant results were
obtained for 85.1% (223/262: rectal) and 86.3% (226/262:
pharyngeal) of specimen sets tested. Concordant AC2 results
(nurse and self-taken specimens) but GC culture-negative
specimens accounted for 6.5% of rectal (17/262) and 7.3% of
pharyngeal (19/262) specimens and for the purposes of analysis
this specimen set combination was not considered discordant.
The remaining 8.4% (22/262) rectal and 6.5% (17/262)
pharyngeal specimen sets were discordant for GC in various
combinations between the culture result and/or the two AC2
results, but it is notable that positive or equivocal GC specimens
were more common in the patient-taken than the nurse-taken
specimen (table 1). Interestingly, of the 22 discordant rectal
specimens, 15 (68.2%) had been sourced from patients, with a
GC culture-positive result from another site (either urethral or
pharynx). Of the 17 patients who generated a pharyngeal
discordant result, 15 (88.2%) had GC culture positive from
another site (either urethral or rectal).
CT rectal and pharyngeal results
A total of 258 study participants had a full set of rectal specimen
results returned (routine SDA swab and self and nurse-taken for
AC2) and the combination of results generated are presented in
table 2. It was not routine clinic practice to perform a SDA CT
test on pharyngeal specimens, but the result of the self and
nurse-taken swabs from 265 study participants are displayed. In
95.3% (246/258) of rectal and 98.1% (260/265) of pharyngeal
specimen sets, concordant CT results were generated. However,
12 rectal and five pharyngeal specimen sets produced discordant
results in various combinations (table 2).
Comparison of nurse versus patient-taken swabs
The final sensitivity and specificity of both the nurse and self-
taken swabs was compared with the gold standard routine clinic
result, which for GC was culture and for CT was the SDA result
(table 3). No significant difference in either the sensitivity or
specificity was observed between the self and nurse-taken rectal
swab for the detection of either GC or CT (table 3). Similarly,
although no significant difference in sensitivity was observed
between the nurse and self-taken pharyngeal swabs for GC, the
difference in specificity was found to be significant (table 3).
Due to the absence of a gold standard clinic result for
pharyngeal chlamydia these data could not be presented.
DISCUSSION
Non-invasively collected specimens such as self-taken vaginal
swabs and first catch urines have enabled population-based
prevalence studies and community screening programmes for
CT in heterosexual individuals. This study was undertaken to
determine if self-taken rectal and pharyngeal specimens were
appropriate for the detection of GC and CT in MSM. No
significant difference in sensitivity was observed between the
nurse-taken and the patient-taken swabs for the detection of
either GC or CT in the rectum and GC in the pharynx, when
using the AC2 test (table 3). Clearly, if provided with detailed
instructions, MSM are as equally capable of collecting rectal and
pharyngeal specimens as clinic staff.
Interestingly, when examining the specificity of the phar-
yngeal GC specimens, a significant difference was observed
between the nurse and patient-taken swabs, with the patient-
taken swabs having a higher number of false GC-positive results
(tables 1 and 3). It is possible that high rates of concurrent GC
infection in different anatomical sites in these specific indivi-
duals may explain this, as 90.9% (10/11) of patients who
generated a false GC-positive self-taken pharyngeal specimen
were culture positive at either the rectum or the urethra. It
could be speculated that patients were more likely to cross-
contaminate the specimens between sites because of inexperi-
ence in handling the collection materials, but the clinical
implications of this are probably minimal. However, this,
Table 3 The sensitivity and specificity of self-taken and nurse-taken swabs for the detection of CT and GC
Method of
collection
Sensitivity
(95% CI)
p Value
(no of true
positives)
Specificity
(95% CI)
p Value
(no of true
negatives)
Rectal GC*
(n = 262)
Nurse 94.9% (82.7 to 99.4)
1.00 (39)
90.1% (85.4 to 93.7) 0.30 (223)
Patient 92.3% (79.1 to 98.4) 87.9% (82.9 to 91.9)
Pharyngeal GC*
(n = 262)
Nurse 88.2% (63.6 to 98.5)
0.50 (17)
91.8% (87.7 to 94.9) 0.006 (245)
Patient 100% (80.5 to 100) 87.8% (83.0 to 91.6)
Rectal CT{
(n = 258)
Nurse 80.0% (63.1 to 91.6)
0.13 (35)
99.6% (97.5 to 100) 0.25 (223)
Patient 91.4% (76.9 to 98.2) 98.2% (95.5 to 99.5)
*Nurse and patient-taken swabs (tested by AC2) compared with GC culture results.
{Nurse and patient taken swabs (tested by AC2) compared with clinic strand displacement assay (SDA) result.
CT, C trachomatis; GC, N gonorrhoeae.
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combined with concerns raised by previous studies that high-
light that CT nucleic acids are present at detectable levels in the
genitourinary environment, suggest that issues regarding speci-
men purity should be reinforced to patients before self-
collection kits are distributed.8
The high sensitivities and conversely low specificity values
generated for the GC component of this study (table 3) is a
direct consequence of comparing the AC2 result with the gold
standard GC bacteriological culture, which is inevitably less
sensitive. The reduced sensitivity of GC culture in the rectum
and pharynx has previously been documented and it has also
been recommended that molecular tests may be more appro-
priate for the detection of GC infection in these sites.9 In reality,
how a laboratory actually provides a highly sensitive and
specific service for GC detection in extragenital sites is
actually extremely problematical because of the higher
numbers of commensal Neisseria spp in these sites and the
low specificity of some GC NAAT platforms.6 The significant
number of asymptomatic patients identified in this study
with negative GC cultures but positive AC2 GC results
highlights the problems associated with detecting GC in
rectal and pharyngeal sites, and indeed the high number of
patients who will go undetected and untreated if culture alone is
the only method used for diagnosis. It should also be
reiterated that GC NAAT platforms are not equal in perfor-
mance. In this study the AC2 assay was used, which has
been shown to be highly specific and caution should be applied
before extrapolating the data presented here to other GC NAAT
tests.
Interestingly, in this study the sensitivity of the CT
component of the AC2 test, when compared with the SDA
result, was lower (tables 2 and 3). This is in sharp contrast to
many previous studies, all of which have shown the AC2 to be a
more sensitive assay than SDA when testing urine, cervical
swabs and vaginal swabs.10–12 Participants who had a positive
SDA result but were AC2 CT negative were not repeated during
this study, but were re-examined using the CT monospecifc test
at the end when the results were unblinded. Upon re-
examination, seven AC2 CT-negative specimens (five nurse
and two self-taken) generated a positive using the monospecific
CT test and were therefore given a CT equivocal status (table 2).
In our sensitivity and specificity calculations (using a very
conservative approach) equivocal results were regarded as
negative and therefore this explains the anomaly in AC2
sensitivity. One possible reason for seven clinical specimens
initially being CT AC2 false negatives is that, despite the high
throughput nature of the AC2 testing work performed in the
study, it was conducted by hand pippetting rather than using a
robot and each AC2 test does not contain an internal control. It
is recognised that the introduction of automation not only
improves turnaround times, and reduces staff time, but also
improves the reliability of clinical results.13 Such a problem was
not highlighted when examining the GC results because the GC
data were compared with a less sensitive, more forgiving, gold
standard.
This is the first study to provide conclusive data that self-
taken swabs from both rectal and pharyngeal sites are
comparable to those taken by the nurse for the detection of
both CT and GC, when using the AC2 test. It is hoped that the
findings from this study will enable the development of non-
GUM community STI screening programmes within MSM
populations, thereby improving both individual and public
health. This strategy is currently being evaluated by this
research group.
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